Bio-Rad Laboratories
BIO
$470.55
Share price
2.12%
Change (1 day)
-18.03%
Change (1 year)
Categories
Bio-Rad Laboratories, Inc. is an American manufacturer of products for the life science research and clinical diagnostics markets.
Operating Margin for Bio-Rad Laboratories (BIO)
Operating Margin as of March 2023 (TTM): -279.56%
According to Bio-Rad Laboratories's latest financial reports and stock price the company's current Operating Margin is -279.56%. At the end of 2021 the company had an Operating Margin of 186.08%.
Operating Margin history for Bio-Rad Laboratories from 2001 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | 186.08% | -3.48% |
| 2020 | 192.79% | 97.1% |
| 2019 | 97.81% | 336.81% |
| 2018 | 22.39% | 394.57% |
| 2017 | 4.53% | 125.31% |
| 2016 | 2.01% | -72.18% |
| 2015 | 7.22% | 19.4% |
| 2014 | 6.05% | 14.78% |
| 2013 | 5.27% | -51.09% |
| 2012 | 10.77% | -5.25% |
| 2011 | 11.37% | -0.53% |
| 2010 | 11.43% | 9.75% |
| 2009 | 10.42% | 28.65% |
| 2008 | 8.10% | -2.12% |
| 2007 | 8.27% | -25.81% |
| 2006 | 11.15% | 41.01% |
| 2005 | 7.91% | -11.45% |
| 2004 | 8.93% | -21.2% |
| 2003 | 11.33% | -3.12% |
| 2002 | 11.70% | 47.16% |
| 2001 | 7.95% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 24.28% | -108.69% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | 17.44% | -106.24% | 🇺🇸 USA |
 Agilent Technologies A | 21.96% | -107.86% | 🇺🇸 USA |
 Becton Dickinson BDX | 9.19% | -103.29% | 🇺🇸 USA |
 General Electric GE | -4.96% | -98.23% | 🇺🇸 USA |
 Danaher DHR | 25.79% | -109.23% | 🇺🇸 USA |
 PerkinElmer
PKI | 16.81% | -106.01% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.